Biological performance of a size-fractionated core-shell tantalum oxide nanoparticle X-ray contrast agent

Investigative Radiology

Volumn 47, Issue 10, 2012, Pages 578-587

  Torres, Andrew S ^a   Bonitatibus, Peter J ^a   Colborn, Robert E ^a   Goddard, Gregory D ^a   Fitzgerald, Paul F ^a   Lee, Brian D ^a   Marino, Michael E ^a  

^a GE GLOBAL RESEARCH   (United States)

Author keywords

computed tomography; contrast media; nanoparticle; tantalum oxide

Indexed keywords

2 DIETHYLPHOSPHATOETHYLSILANE TANTALUM OXIDE NANOPARTICLE; CONTRAST MEDIUM; IOPROMIDE; METAL NANOPARTICLE; TANTALUM; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG RETENTION; MALE; NONHUMAN; PLASMA HALF LIFE; PRIORITY JOURNAL; RADIATION DOSE; RAT;

EID: 84866317099     PISSN: 00209996     EISSN: 15360210     Source Type: Journal    
DOI: 10.1097/RLI.0b013e318260fc40     Document Type: Article

References (22)

1. Brix G, Lechel U, Petersheim M, et al. Dynamic contrast-enhanced CT studies: balancing patient exposure and image noise. Invest Radiol. 2011;46:64-70 10.1097/RLI.1090b1013e3181f1033b1035.
2. Ding A, Mille MM, Liu T, et al. Extension of RPI-adult male and female computational phantoms to obese patients and a Monte Carlo study of the effect on CT imaging dose. Phys Med Biol. 2012;57:2441.
3. McClennan BL, Preston M. Hickey memorial lecture. Ionic and nonionic io-dinated contrast media: evolution and strategies for use. AJR Am J Roentgenol. 1990;155:225-233. (Pubitemid 20227844)
4. Oh MH, Lee N, Kim H, et al. Large-scale synthesis of bioinert tantalum oxide nanoparticles for X-ray computed tomography imaging and bimodal image-guided sentinel lymph node mapping. J Am Chem Soc. 2011;133:5508-5515.
5. McIntire GL, Bacon ER, Illig KJ, et al. Time course of nodal enhancement with CT X-ray nanoparticle contrast agents: effect of particle size and chemical structure. Invest Radiol. 2000;35:91-96. (Pubitemid 30078268)
6. Bonitatibus PJ, Torres AS, Goddard GD, et al. Synthesis, characterization, and computed tomography imaging of a tantalum oxide nanoparticle imaging agent. Chem Commun. 2010;46:8956.
7. Hainfeld JF, Slatkin DN, Focella TM, et al. Gold nanoparticles: a new X-ray contrast agent. Br J Radiol. 2006;79:248-253.
8. Cai QY, Kim SH, Choi KS, et al. Colloidal gold nanoparticles as a blood-pool contrast agent for X-ray computed tomography in mice. Invest Radiol. 2007;42:797-806. (Pubitemid 350126561)
9. Kim D, Park S, Lee JH, et al. Antibiofouling polymer-coated gold nanoparticles as a contrast agent for invivo X-ray computed tomography imaging. JAm Chem Soc. 2007;129:7661-7665. (Pubitemid 46981930)
10. Rabin O, Manuel Perez J, Grimm J, et al. An X-ray computed tomography imaging agent based on long-circulating bismuth sulphide nanoparticles. Nature Mater. 2006;5:118-122. (Pubitemid 43177900)
11. Sweeney SF, Woehrle GH, Hutchison JE. Rapid purification and size separation of gold nanoparticles via diafiltration. J Am Chem Soc. 2006;128:3190-3197.
12. Roth R, Akin M, Deligonul U, et al. Influence of radiographic contrast media viscosity to flow through coronary angiographic catheters. Cathet Cardiovasc Diagn. 1991;22:290-294.
13. Lorusso V, Luzzani F, Bertani F, et al. Pharmacokinetics and tissue distribution of iomeprol in animals. Eur J Radiol. 1994;18(suppl 1):S13-S20. (Pubitemid 24140173)
14. Zuev MG, Larionov LP. Tantalum X-ray contrast media (solid-state chemistry for medicine series). Inorg Mater. 2004;40:671-672.
15. Aspelin P, Aubry P, Fransson SG, et al. Nephrotoxic effects in high-risk patients undergoing angiography. N Engl J Med. 2003;348:491-499. (Pubitemid 36159884)
16. Mettler FA Jr, Bhargavan M, Faulkner K, et al. Radiologic and nuclear medicine studies in the United States and worldwide: frequency, radiation dose, and comparison with other radiation sources-1950-2007. Radiology. 2009; 253:520-531.
17. Wistrand LG, Rogstad A, Hagelin G, et al. GE-145, a new low-osmolar dimeric radiographic contrast medium. Acta Radiol. 2010;51:1014-1020.
18. Jakobsen JA. Physiological effects of contrast media for use in multidetector row computed tomography. Eur J Radiol. 2007;62(suppl 1):14-25. (Pubitemid 46766621)
19. Eloy R, Corot C, Belleville J. Contrast media for angiography: physicochemical properties, pharmacokinetics and biocompatibility. Clin Mater. 1991;7:89-197.
20. Yu SB, Watson AD. Metal-based X-ray contrast media. Chem Rev. 1999; 99:2353-2378.
21. Yang WM, Liu YW, Zhang Q, et al. Biomedical response of tantalum oxide films deposited by DC reactive unbalanced magnetron sputtering. Surf Coat Technol. 2007;201:8062-8065. (Pubitemid 47074221)
22. Wellinghoff ST, Timmons SF. Tantalum oxide-polymer composites. In: Attia YA, ed. Sol-Gel Processing and Applications. New York, NY: Plenum Press; 1994:141-154.